In 1951, Henrietta Lacks, a young black woman from Baltimore, died of cancer. However, before her death a small sample of her cells were taken from her without her knowledge, and these cells did not die. Unlike every other previous sample of human cells, these continued to grow and multiply and still do so today. The HeLa cells became the first ‘immortalised human cell line’ and have helped both save and create millions of lives ever since. Video by Dan John Animation by Lily Baker.
Category: life extension – Page 193
Heart 10 years younger thanks to the longevity protein
A ‘longevity protein’ discovered in the DNA of centenarians promises to rejuvenate the heart by at least 10 years. Hope comes from a preclinical study coordinated by Annibale Puca of the MultiMedica group in Milan and Paolo Madeddu of the University of Bristol in the United Kingdom, funded by the British Heart Foundation and the Italian Ministry of Health and published in ‘Cardiovascular Research’, a journal of the European Society of Cardiology (ESC).
Investing in the Age of Longevity 2022 — Tom Benson — Mitrix Bio
Talk Title: Human Age Reversal through Mitochondrial Transplantation.
Tom Benson, CEO at Mitrix Bio, presents at Investing in the Age of Longevity 2022. In his talk, Tom outlines the effect of mitochondria on aging, and how mitochondrial transplantation can be used for age reversal. Showcasing how Mitrix Bio is pioneering the application of this technique, Tom also presents the company’s roadmap for clinical trials and commercialisation of its platform.
Download the presentation slides: https://bit.ly/IAL22-Tom-Benson.
Investing in the Age of Longevity 2022 was held in London on 17 November 2022. The one-day masterclass featured presentations from scientists and business leaders at the cutting edge of the field, giving participants the inside track on the latest aging-related discoveries and investment opportunities.
Download the event programme: https://www.masterinvestor.co.uk/IAL22
Find out more about past and upcoming Master Investor events: https://events.masterinvestor.co.uk
Dr. Rob Konrad presenting at Rejuvenation Startup Summit 2022
We use cookies on our website. Some of them are essential, while others help us to improve this website and your experience. If you are under 16 and wish to give consent to optional services, you must ask your legal guardians for permission. We use cookies and other technologies on our website. Some of them are essential, while others help us to improve this website and your experience. Personal data may be processed (e.g. IP addresses), for example for personalized ads and content or ad and content measurement. You can find more information about the use of your data in our privacy policy. You can revoke or adjust your selection at any time under Settings.
A fountain of youth for dogs? This S.F. startup says it’s on the way
Every pet owner knows the heartbreaking reality: Companion animals’ lives are shorter than ours.
Now, a San Francisco biotech startup is working on drugs to help dogs live longer, healthier lives.
“We want to give people more time with the pets they love,” said Celine Halioua, 28, a scientist who founded Loyal in 2019 with no more than an idea. She’s now CEO of a 58-person company backed by $60 million in venture capital. “Everyone has stories about beloved pets gone too soon.”
Scientists make new discovery about reversing the ageing process
Researchers look at DNA of lab mice and ultimately reverse ageing process Related: Empowered Aging Scientists have made a new discovery about how to reverse the ageing process through looking at the way in which cells in DNA are organised. In a new study published in Cell, David Sinclair, who is a professor of genetics at Harvard Medical School, and his team described how they looked at a genome, which is called epigenome, in mice to study the ageing process.
Combining Multiple Maps Reveals New Genetic Risk Factors for Age-Related Macular Degeneration
Summary: Study uncovers new genetic risk factors for age-related macular degeneration, a leading cause of vision loss in adults.
Source: PLOS
Combining a map of gene regulatory sites with disease-associated loci has uncovered a new genetic risk factor of adult-onset macular degeneration (AMD), according to a new study publishing January 17 in the open-access journal PLOS Biology by Ran Elkon and Ruth Ashery-Padan of Tel Aviv University, Israel, and colleagues.
